BridgeBio Oncology Therapeutics (BBOT) Amortizatization of Intangibles (2025 - 2026)
BridgeBio Oncology Therapeutics (BBOT) posted Amortizatization of Intangibles of $74000.0 for Q1 2026, down 32.73% sequentially from $110000.0 in Q4 2025, and down 81.86% YoY from $408000.0 in Q1 2025.
BridgeBio Oncology Therapeutics (BBOT) Amortizatization of Intangibles (2025 - 2026) Analysis & Trends
BridgeBio Oncology Therapeutics has reported Amortizatization of Intangibles for 2 years, with the latest figure at $74000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 81.86% year-over-year to $74000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $592000.0 (changed N/A YoY) and the FY2025 annual result came in at $330000.0, changed N/A from the prior year.
- Amortizatization of Intangibles slipped to $74000.0 in Q1 2026 per BBOT's latest filing, from $110000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $408000.0 in Q1 2025 and troughed at $74000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.33 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 678,000.00 |
| 10 | BridgeBio Oncology Therapeutics | 726.38 Mn | 500.67 Mn | - | -405,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -405,000.00 |
| Jun 30, 2026 | -405,000.00 |
| Mar 31, 2026 | 74,000.00 |
| Mar 31, 2026 | 74,000.00 |
| Dec 31, 2025 | 110,000.00 |
| Dec 31, 2025 | 110,000.00 |
| Mar 31, 2025 | 408,000.00 |
| Mar 31, 2025 | 408,000.00 |